249 related articles for article (PubMed ID: 20083343)
21. NIP1/DUOXA1 expression in epithelial breast cancer cells: regulation of cell adhesion and actin dynamics.
Ostrakhovitch EA; Li SS
Breast Cancer Res Treat; 2010 Feb; 119(3):773-86. PubMed ID: 19322654
[TBL] [Abstract][Full Text] [Related]
22. Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1.
Shevde LA; Samant RS; Goldberg SF; Sikaneta T; Alessandrini A; Donahue HJ; Mauger DT; Welch DR
Exp Cell Res; 2002 Feb; 273(2):229-39. PubMed ID: 11822878
[TBL] [Abstract][Full Text] [Related]
23. Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules.
Nizamutdinova IT; Lee GW; Lee JS; Cho MK; Son KH; Jeon SJ; Kang SS; Kim YS; Lee JH; Seo HG; Chang KC; Kim HJ
Carcinogenesis; 2008 Oct; 29(10):1885-92. PubMed ID: 18586687
[TBL] [Abstract][Full Text] [Related]
24. Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1.
Lee JH; Welch DR
Cancer Res; 1997 Jun; 57(12):2384-7. PubMed ID: 9192814
[TBL] [Abstract][Full Text] [Related]
25. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
Sheikh MS; Shao ZM; Hussain A; Clemmons DR; Chen JC; Roberts CT; LeRoith D; Fontana JA
J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication.
Saunders MM; Seraj MJ; Li Z; Zhou Z; Winter CR; Welch DR; Donahue HJ
Cancer Res; 2001 Mar; 61(5):1765-7. PubMed ID: 11280719
[TBL] [Abstract][Full Text] [Related]
27. Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
Kasper G; Reule M; Tschirschmann M; Dankert N; Stout-Weider K; Lauster R; Schrock E; Mennerich D; Duda GN; Lehmann KE
BMC Cancer; 2007 Jan; 7():12. PubMed ID: 17233884
[TBL] [Abstract][Full Text] [Related]
28. Proteomics-based strategy to delineate the molecular mechanisms of the metastasis suppressor gene BRMS1.
Rivera J; Megias D; Bravo J
J Proteome Res; 2007 Oct; 6(10):4006-18. PubMed ID: 17854218
[TBL] [Abstract][Full Text] [Related]
29. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer.
Dunn SE; Ehrlich M; Sharp NJ; Reiss K; Solomon G; Hawkins R; Baserga R; Barrett JC
Cancer Res; 1998 Aug; 58(15):3353-61. PubMed ID: 9699666
[TBL] [Abstract][Full Text] [Related]
30. Expression of estrogen receptors in estrogen receptor-negative human breast carcinoma cells: modulation of epidermal growth factor-receptor (EGF-R) and transforming growth factor alpha (TGF alpha) gene expression.
Sheikh MS; Shao ZM; Chen JC; Li XS; Hussain A; Fontana JA
J Cell Biochem; 1994 Mar; 54(3):289-98. PubMed ID: 8200909
[TBL] [Abstract][Full Text] [Related]
31. Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells.
Glinsky VV; Huflejt ME; Glinsky GV; Deutscher SL; Quinn TP
Cancer Res; 2000 May; 60(10):2584-8. PubMed ID: 10825125
[TBL] [Abstract][Full Text] [Related]
32. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
[TBL] [Abstract][Full Text] [Related]
33. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
34. CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1).
Wang HS; Hung Y; Su CH; Peng ST; Guo YJ; Lai MC; Liu CY; Hsu JW
Exp Cell Res; 2005 Mar; 304(1):116-26. PubMed ID: 15707579
[TBL] [Abstract][Full Text] [Related]
35. [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells.
Lee HS; Seo EY; Kang NE; Kim WK
J Nutr Biochem; 2008 May; 19(5):313-9. PubMed ID: 17683926
[TBL] [Abstract][Full Text] [Related]
36. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.
Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS
J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434
[TBL] [Abstract][Full Text] [Related]
37. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
38. A comparison of breast cancer tumor cells with varying expression of the Her2/neu receptor by Raman microspectroscopic imaging.
Hartsuiker L; Zeijen NJ; Terstappen LW; Otto C
Analyst; 2010 Dec; 135(12):3220-6. PubMed ID: 20978707
[TBL] [Abstract][Full Text] [Related]
39. Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells.
Kapoor P; Saunders MM; Li Z; Zhou Z; Sheaffer N; Kunze EL; Samant RS; Welch DR; Donahue HJ
Int J Cancer; 2004 Sep; 111(5):693-7. PubMed ID: 15252837
[TBL] [Abstract][Full Text] [Related]
40. mRNA expression of the putative antimetastatic gene BRMS1 and of apoptosis-related genes in breast cancer.
Schneider J; Gómez-Esquer F; Díaz-Gil G; Torrejón R; Pollán M
Cancer Genomics Proteomics; 2011; 8(4):195-7. PubMed ID: 21737612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
